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The role of metabolism in ovarian aging is poorly described, despite the fact that ovaries fail earlier than most
other organs. Growing interest in ovarian function is being driven by recent evidence that mammalian females
routinely generate new oocytes during adult life through the activity of germline stem cells. In this perspec-
tive, we overview the female reproductive system as a powerful and clinically relevant model to understand
links between aging andmetabolism, andwe discuss new concepts for how oocytes and their precursor cells
might be altered metabolically to sustain or increase ovarian function and fertility in women.Introduction
Early in life’s history, a complex signaling network evolved to
maximize the number of descendants a cell could produce in a
particular environment. This ancient network, which still exists
in cells today, promotes growth and reproduction when the
environment is favorable and suppresses these activities during
harsh times (Kirkwood, 1987). This system explains in large part
why many species gain health benefits from dietary restriction
(DR) and how the body adapts to changing supplies and
demands for energy. As we learn more about this survival
network, it is becoming increasingly plausible to stimulate it
pharmacologically. Indeed, molecules that mimic DR are in
development for treatment of many aging-related health issues,
such as type II diabetes, inflammation, andmuscle degeneration
(Blum et al., 2011; Chiba et al., 2010). Despite rapid progress in
this area, one aspect of human health that has been largely
neglected is reproductive potential.
The Ovary as a Model for Aging Studies
The main functional unit of mammalian ovaries is a multicellular
structure referred to as the follicle (Gougeon, 1996). Each follicle
is composed of an oocyte, which is a partially differentiated
female germ cell arrested in prophase of the first meiotic cell
division, enclosed by one or more layers of specialized somatic
cells that support the oocyte during its growth. Starting with
a resting (primordial) follicle that contains an oocyte and just a
single layer of somatic granulosa cells, each follicle attempts
to complete progressive developmental stages associated with
extensive replication of the granulosa cell population and the
acquirement of a second somatic cell type known as theca-
interstitial cells. Through complex cell-to-cell interactions, the
oocyte gains developmental competence so that it can initiate
embryogenesis if fertilized after ovulation (Matzuk et al., 2002;
Orisaka et al., 2009). Simultaneously, the follicular somatic cells
become highly responsive to circulating factors and secrete a
spectrum of hormones that exert effects both locally in the
ovaries and in many other tissues including the brain, bones,
skin, and cardiovascular system (Buckler, 2005; Prior, 1998).838 Cell Metabolism 17, June 4, 2013 ª2013 Elsevier Inc.Because of the central importance of follicles to maintaining
endocrine function of the female gonads as well as to fertility,
ovarian life span is dictated by the number of follicles present
in the tissue—an endpoint often referred to as the ‘‘ovarian
reserve.’’ Since the 1950s, it was widely believed that females
of most mammalian species are provided with a nonrenewable
ovarian reserve around the time of birth (Zuckerman, 1951).
Following growth activation, each primordial follicle in this
reserve either completes maturation for release of its enclosed
oocyte at ovulation, or undergoes a degenerative process
referred to as atresia. Historical studies of mouse, rat, and
human ovaries have shown that atresia actually claims the vast
majority of follicles present in the gonads, ultimately leading to
complete exhaustion of the ovarian reserve long before death
due to advanced chronological age (Faddy et al., 1992; Gosden
et al., 1983; Richardson et al., 1987). More contemporary work
has revealed that this massive oocyte loss occurs largely
through apoptosis, involving an array of genes and signaling
pathways that share many similarities to the regulation of
apoptosis in other organ systems (Tilly, 2001). Follicle loss can
be dramatically accelerated by external insults, including
chemotherapy, radiation, and environmental toxicants (Tilly,
2001), leading to the premature onset of many health problems
associated with natural menopause.
The concept of irreversible exhaustion of the ovarian reserve
in mammals is based on the presumed absence of replicative
germ cells in postnatal ovarian tissue that could give rise to
new oocytes. This contrasts sharply with observations from
females of nonmammalian species, including flies and fish,
which retain germline stem cells (GSCs) that actively support
oocyte renewal during adult life (Kirilly and Xie, 2007; Nakamura
et al., 2010). However, in 2004 a study was published offering
multiple lines of evidence for the existence of female GSCs
(or, more appropriately, oogonial stem cells or OSCs, to be
consistent with the nomenclature applied to spermatogonial
stem cells—their male counterparts in the adult testis) in
postnatal ovaries of mice that generate oocytes to form new
follicles (Johnson et al., 2004). These findings countered dogma
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Nonetheless, the possibility that the ovarian reserve could be
replenished became a focal point of investigation for many labo-
ratories (Tilly et al., 2009). These efforts ultimately led to the isola-
tion of OSCs from neonatal and adult mouse ovaries by at least
three groups using different strategies (Pacchiarotti et al., 2010;
White et al., 2012; Zou et al., 2009), and the purification of a
similar population of oocyte-producing progenitor germ cells
from adult human ovaries (White et al., 2012). In addition, studies
in mice have shown that when OSCs are reintroduced into adult
ovaries, the cells differentiate to form follicle-enclosed oocytes
that mature, ovulate, and fertilize to produce viable embryos
and offspring (White et al., 2012; Zou et al., 2009). In lower organ-
isms, function of these types of germ cells has been tied to
nutrient availability (McLeod et al., 2010; Jasper and Jones,
2010) and can even govern the pace of aging (Hsin and Kenyon,
1999; Flatt et al., 2008). These paradigm-shifting studies
therefore provide a framework for introduction of OSCs into
discussions of how female fertility and ovarian life span might
be modulated in mammals.
Dietary Restriction, Longevity Genes, and Female
Fertility
Mice and rats maintained on DR have reduced fertility or are
completely infertile (Selesniemi et al., 2008; Visscher et al.,
1952). Similarly, women below ideal body weight due to self-
imposed DR have reduced fertility (Bates, 1985) and exhibit
marked changes in gonadotropic hormones to levels that
resemble those in women with ovarian insufficiency. Although
the common wisdom is that DR negatively impacts fertility, it is
less well known that DR can also have a positive impact. Almost
a century ago, studies of rats noted that the ‘‘menopause has
been postponed [by DR] long beyond the age at which it naturally
appears’’ (Osborne et al., 1917). While rodents do not undergo a
true menopause, this work, and several rodent studies that fol-
lowed, clearly established that moderate DR extends functional
ovarian life span in mammals.
At first glance, this finding appears at odds with the ‘‘Dispos-
able Soma Theory,’’ in which the longevity of a species is a direct
result of how it divides its resources between reproduction and
protecting the soma (Kirkwood and Holliday, 1979). But it is
not. Through analysis of physiological and ecological data on
mouse survival and fertility, as well as life-history modeling,
the temporary cessation of active fertility exhibited during
DR in mice is believed to free up energy that can be used to
enhance maintenance, thereby preserving viability and fertility
for when the period of famine has passed (Shanley and Kirk-
wood, 2000).
Consistent with this idea, longevity can be achieved without
sacrificing fertile potential in many species, including Podospora
anserina (van Diepeningen et al., 2010), Saccharomyces
cerevisiae (Jiang et al., 2000), Caenorhabditis elegans (Wood
et al., 2004), and Drosophila melanogaster (Grandison et al.,
2009). In nematodes, starvation shuts down reproduction
through enforced quiescence of GSCs, which resume active
gametogenesis for offspring production upon refeeding (Angelo
and Van Gilst, 2009). In flies, altering the balance of specific
amino acids can increase longevity without reducing fertility(Grandison et al., 2009). The DR mimetic and SIRT1 activator
resveratrol, which boosts mitochondrial function and extends
life span in C. elegans and Drosophila, increases the number of
eggs laid per organism (Wood et al., 2004). Together these
data indicate that during adversity, many organisms downregu-
late fertility but simultaneously upregulate defense systems
to preserve the germline. When conditions improve, fertility
rebounds.
A similar situation may hold true for mammals. A stepwise
40% reduction in caloric intake in mice instituted after sexual
maturation showed that while reproductive capacity is impaired
during DR, these animals remain fertile much longer than contin-
uously ad libitum (AL)-fed controls once the DR females are
allowed to resume AL feeding (Selesniemi et al., 2008). Further-
more, at advanced ages when offspring number per litter deliv-
ered by AL-fed females is close to zero, the number of pups
born per litter by female mice maintained on DR for several
months and then returned to an AL diet remains remarkably
high (Selesniemi et al., 2008). The conclusion from these rodent
studies is that if the DR regimen is mild, or if normal food intake is
restored after a period of moderate DR, fertility is not negatively
impacted and can actually be maintained for longer. In accor-
dance with this, infertile women on DR rapidly regain their
fertility if they increase their food consumption (Bates, 1985).
An intriguing possibility is that DR mimetics provided to women
on a normal diet could provide a means to activate germ cell
defense networks, thereby maintaining or restoring oocyte qual-
ity and extending fertile life span.
Such findings underscore the need to better define molecular
mechanisms underlying organismal responses to DR or DR
mimetics, and to then test these findings in the context of female
fertility. The original idea that DR works passively by simply
reducing metabolic rate or the generation of reactive oxygen
species (ROS) has been largely discarded. In its place is a funda-
mentally different model in which DR works by triggering an
active response that evolved to promote organismal survival dur-
ing harsh conditions (Guarente, 2008; Kirkwood, 2005). At the
center of this response are so-called ‘‘longevity regulatory path-
ways’’ (Figure 1).
Although there are hundreds of longevity genes in dozens of
species, four signaling pathways stand out as particularly impor-
tant mediators of the DR response. These are insulin/insulin-like
growth factor-1 (IGF-1) signaling, the mammalian target of rapa-
mycin (mTOR) pathway, AMP-activated kinase (AMPK), and sir-
tuins. With the exception of sirtuins, which were first identified as
mediators of gene silencing (Klar et al., 1979), these pathways
were discovered for their roles in nutrient sensing decades
before any role in aging was suspected. In the past few years,
however, the fields of metabolism and aging have been united
by the realization that all four of these metabolic sensors in
eukaryotes form a complex regulatory network that responds
to changes in a cell’s internal and external environment by stor-
ing or utilizing energy for processes that boost cellular defenses
against tissue damage, deterioration, and disease (Canto´ and
Auwerx, 2009; Katewa and Kapahi, 2011).
As one might expect, at least some of these pathways appear
operational in female germ cells, although much of this work has
focused on oocyte growth activation and not egg quality (Reddy
et al., 2008; Li et al., 2010). Exceptions include reports linkingCell Metabolism 17, June 4, 2013 ª2013 Elsevier Inc. 839
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Figure 1. Longevity Pathways that Promote
Health and Survival
Current data indicate that environmental signals
alter the pace of aging by modulating key metabolic
sensors, such as SIRT1 and AMPK. These path-
ways interact with both mTOR and insulin/IGF-1 to
control cell growth and energy intake. Obesity and
aging reduce the ratios of NAD+/NADH and AMP/
ATP, whereas DR has the opposite effect. Down-
stream, the actions of two transcriptional regula-
tors, PGC-1a and FOXO, induce mitochondrial
function and stress resistance, among other
protective mechanisms. Together, this network
coordinates cellular responses to stress, nutrient
availability, and metabolic demands, with mito-
chondria as key nexus points.
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tase and tensin homolog (PTEN) pathway, which ties into
mTOR signaling, to meiotic progression in oocytes and embry-
onic genome activation in fertilized eggs, respectively (Lee
et al., 2012; Zheng et al., 2010). In addition, several sirtuin family
members are expressed inmouse oocytes. Of particular interest,
loss of sirtuin-3 function in mouse eggs increases mitochondrial
ROS production, leading to impaired preimplantation embryonic
development after fertilization (Kawamura et al., 2010).
Effects of Diet on Egg Quality
Although early reports indicated that reduced dietary food intake
can slow follicle depletion from ovaries in rats and mice (Lintern-
Moore and Everitt, 1978; Nelson et al., 1985), the ovarian reserve
in aged females subjected to DR followed by AL feeding is, like
their age-matched AL-fed counterparts, severely diminished
when compared to that of young adult females (Selesniemi
et al., 2008). Thus, the beneficial effects of DR on female fertility,
fecundity, and offspring survival are apparently not due to main-
tenance of a larger follicle reserve with age. While it is conceiv-
able that the benefits of DR in this model are partly a result of
improved capacity of the uterus of aged females to establish
and support a pregnancy, oocyte donation studies in humans
have demonstrated that aging-related infertility can be effec-
tively overcome by use of oocytes from young adult donors
(Klein and Sauer, 2002; Sauer et al., 1992). In fact, given that
women in their sixties have successfully carried pregnancies to
term as surrogates (Paulson et al., 2002; Sauer et al., 1995),
the single most important factor for determining pregnancy suc-
cess rates in women of advanced maternal age seems to be
oocyte quality and not uterine dysfunction (Navot et al., 1991).
Production of a developmentally competent egg requires the
successful completion of meiosis, ultimately reducing its chro-840 Cell Metabolism 17, June 4, 2013 ª2013 Elsevier Inc.mosome number to one-half once pene-
trated by the sperm at fertilization. The
joining of the male and female pronuclei
in the fertilized egg then restores a normal
chromosome complement in the newly
formed embryo. Unfortunately, the meiotic
cell cycle is highly prone to errors with
increasing age, leading to aneuploid
oocytes (Hassold and Chiu, 1985; Hassold
and Hunt, 2009; Hunt, 1998). Even withovulation continuing in women into their early forties, the quality
of oocytes ovulated by women as they grow older becomes
compromised, elevating the risk for fertilization or embryonic fail-
ure, miscarriage, and birth defects. The most widely known
example of this maternal aging effect is the dramatic rise in risk
for conception of offspring with trisomy 21 or Down syndrome,
which increases from around 2% of clinical pregnancies for
women in their twenties to 30% or more of clinical pregnancies
for women in their forties (Hassold and Chiu, 1985).
The clinical importance of overcoming this aging-related
decline in oocyte quality has become much more relevant as
increasing numbers of women bear children in the second half
of their fertile period (Matthews and Hamilton, 2009; Ventura,
1989). Compounding this problem is the inherent difficulty in cir-
cumventing fertility issues even with assisted reproductive tech-
nologies such as in vitro fertilization (IVF). Since several factors
contribute to the decline in oocyte quality with advancing age,
a widely held assumption in the field of human reproduction is
that any single or simple pharmacological intervention will be
insufficient to overcome this problem. However, very recent
studies with mice indicate that this fundamental belief, like that
of a fixed ovarian reserve at birth, may be invalid. For example,
recent studies show that female mice maintained on DR for
7 months and then allowed to AL feed for 1 month do not exhibit
any of the hallmark features of deteriorating egg quality with age
observed in AL-fed control females (Selesniemi et al., 2011).
Notably, the increased incidence of aneuploidy, meiotic spin-
dle abnormalities, chromosomal misalignment, mitochondrial
aggregation, and declining ATP levels detected in oocytes of
aged AL-fed females is absent in oocytes of aged females previ-
ously maintained on DR. Although additional studies are needed
to address the mechanisms underlying these striking beneficial
effects, aging-related aneuploidy and spindle defects in eggs
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tic manipulation.
Energy, Aging, and the Role of Mitochondria
Whether one is working on metabolism or aging, it is hard to
ignore mitochondria, the structures at the center of cellular
energy production and utilization. These organelles are essential
for generating most of the ATP in the body, which in humans
amounts to about 65 kg per day to meet basic metabolic
demands (To¨rnroth-Horsefield and Neutze, 2008). Other key
functions of mitochondria include calcium buffering, reduction-
oxidation (redox) homeostasis, and programmed cell death
(apoptosis). Mitochondria are continuously moving throughout
the cell—undergoing fusion, fission, and degradation—to elimi-
nate and replace damaged organelles, and to meet fluctuating
energy needs (Palmer et al., 2011).
Data from flies, rats, mice, monkeys, and humans show that as
tissues age, both the number and activity of mitochondria
decline, compensated by an increase in their overall size (Cho
et al., 2011; Ferguson et al., 2005; Short et al., 2005; Wallace,
2001). Mitochondrial dysfunction is associated with, and poten-
tially contributes to, common aging-related diseases such as
atherosclerosis, obesity-induced type II diabetes, sarcopenia,
and neurodegenerative disorders (Di Lisa et al., 2009; Lin and
Beal, 2006; Wallace, 2001). Underlying processes include a
decline in mitochondrial membrane potential and ATP output,
increased activation of the mitochondrial permeability transition
pore (mPTP), mitochondrial membrane depolarization, and
leakage of mitochondrial matrix solutes into the cytoplasm (Di
Lisa et al., 2001; Hafner et al., 2010; Liu et al., 2011; Wallace,
2001).
In addition to aging and aging-related diseases, considerable
evidence supports a role for mitochondria as mediators of the
benefits of DR in rodents and humans (Cerqueira et al., 2011;
Civitarese et al., 2007; Lo´pez-Lluch et al., 2006, 2008). In a vari-
ety of species (Guarente, 2008; Johannsen and Ravussin, 2009),
DR increases mitochondrial number and function. A recent rat
study, however, did not observe this change (Hancock et al.,
2011). The sirtuin-1 (SIRT1)-AMPK network, considered a medi-
ator of DR physiology, acts to raise both the number and activity
of mitochondria (Gerhart-Hines et al., 2007), as do DR mimetics
that stimulate SIRT1 or AMPK activity, such as resveratrol (Baur
et al., 2006; Feige et al., 2008; Funk et al., 2010; Lagouge et al.,
2006), SRT1720 (Minor et al., 2011), and metformin (Canto´ et al.,
2009; Suwa et al., 2006). In flies and nematodes, changes in
mitochondrial metabolism are known to be necessary (Bahador-
ani et al., 2010; Bishop and Guarente, 2007; Zid et al., 2009) and
sufficient (Bahadorani et al., 2010; Durieux et al., 2011; Rera
et al., 2011) for DR to extend life span.
Mitochondria and Oocyte Competency
Of the many potential mechanisms by which DR benefits
oocytes, one of the more plausible is prevention of abnormal
mitochondrial aggregation and decreased ATP levels that occur
in oocytes of aged females (Selesniemi et al., 2011). Many
studies have proposed a link between insufficient ATP availabil-
ity in eggs and defective chromosomal segregation—an
outcome that probably ties to meiotic spindle abnormalities
(Eichenlaub-Ritter et al., 2004; Schon et al., 2000; Zheng et al.,2007). Defective spindle formation would result in a reduced
capacity for successful fertilization and the failure of zygotes pro-
duced from energetically compromised eggs to form viable blas-
tocysts (Bentov et al., 2010). Consistent with this idea, disruption
of mitochondrial oxidative phosphorylation in mouse oocytes
results in reduced potential for meiotic maturation and fertiliza-
tion, as well as decreased preimplantation embryonic develop-
mental potential (Van Blerkom et al., 1995).
Other studies with mice have demonstrated that failure of
oocytes to adequately readjust ATP levels after sperm penetra-
tion disrupts intracellular calcium oscillations (Igarashi et al.,
1997, 2005), which are critical for immediate postfertilization
events that ensure developmental competency of the embryo
(Dumollard et al., 2004; Vitullo and Ozil, 1992). In human eggs,
higher ATP levels have been correlated with a greater potential
for successful embryonic development and implantation (Van
Blerkom et al., 1995). These findings, along with observations
that mitochondria in oocytes of women in their forties frequently
exhibit swelling and abnormal cristae (Mu¨ller-Ho¨cker et al.,
1996), collectively support the idea that impaired bioenergetic
capacity in oocytes is a primary contributor to declining egg
and embryo quality with advancing maternal age.
Additional aspects of mitochondrial physiology must be
considered when evaluating a central role for these organelles
in oocyte development, meioticmaturation, fertilization, and pre-
implantation embryonic competency. Obviously, the generation
of ROS during the oxidative phosphorylation steps associated
with ATP production is closely linked to mitochondrial bioener-
getics. In turn, it may be of little surprise that studies of mice
have reported chronic antioxidant treatment throughout adult
life can sustain egg quality in aging females (Tarı´n et al.,
2002a). Unfortunately, the function of other cells and tissues in
the reproductive tract is simultaneously impaired by this
approach, with excessive fetal loss and diminished offspring
numbers noted (Tarı´n et al., 2002b). Accordingly, long-term sys-
temic administration of antioxidants has little, if any, clinical
application for improving human female fertility.
On amore basic level, a striking aspect of mitochondrial phys-
iology that warrants consideration is the amplification of mito-
chondrial numbers as human oocytes develop from their most
immature state containing between 5 and 10 3 103 mitochon-
dria, to mature metaphase II eggs containing 1–5 3 105 or
more mitochondria (Jansen and Burton, 2004; Piko´ and Matsu-
moto, 1976). The reasons for this tremendous expansion of
mitochondrial numbers during oocyte maturation are not fully
understood. One belief is that the oocyte is actively preparing
itself for the increased energy demands of successful fertilization
and early cleavage divisions associated with embryonic devel-
opment. This seems reasonable, especially if one considers
that the machinery required for mitochondrial replication is shut
off at themetaphase II egg stage and is not reactivated in the em-
bryo until after the blastocyst implants in the uterinewall (Larsson
et al., 1998). Accordingly, one would expect a steep decline in
mitochondrial numbers as an embryo expands from the one-
cell zygote to a blastocyst containing 100 or more cells, a predic-
tion supported by assessment of mitochondrial DNA (mtDNA)
content during preimplantation embryogenesis (Spikings et al.,
2007; Wai et al., 2008) and mitochondrial numbers per cell in
blastocyst stage embryos (Van Blerkom, 2008).Cell Metabolism 17, June 4, 2013 ª2013 Elsevier Inc. 841
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numbers of mitochondria, which contain one to ten copies of
mtDNA per organelle, may actually be a more reliable indicator
of the competence of a given oocyte. Past studies have shown
that mtDNA copy numbers in oocytes and early stage embryos
positively correlate with fertilization and developmental poten-
tial, respectively (Santos et al., 2006; Spikings et al., 2006). In
fact, successful embryogenesis has been tied to threshold levels
of mtDNA content per egg at the time of fertilization, with those
oocytes at the low range of this threshold more prone to failed
maturation, reduced fertilization rates, and embryonic develop-
mental arrest (El Shourbagy et al., 2006; Piko´ and Taylor, 1987;
Reynier et al., 2001; Santos et al., 2006; Wai et al., 2010). In addi-
tion, studies of porcine oocytes have revealed that suppression
of mtDNA replication during in vitro maturation to the metaphase
II egg stage results in reduced fertilization competence aswell as
preimplantation embryonic developmental arrest, and that the
severity of these outcomes is tightly linked to aminimal threshold
copy number of mtDNA (Spikings et al., 2007).
Another intriguing feature of the oocyte is that its mitochondria
tend to be very small (%1 mm in diameter), with electron-dense
matrices and few cristae. Despite these structural features,
oocyte mitochondria are highly active and produce the majority
of energy needed by the egg and early embryo (Dumollard
et al., 2007; Motta et al., 2000; Van Blerkom et al., 1995). After
fertilization, mitochondria in developing embryos undergo strik-
ing ultrastructural changes. By the time of blastocyst formation,
these organelles have acquired an elongated appearance with
complex cristae and less electron-dense matrices, more typical
of mitochondria in somatic cells (Sathananthan and Trounson,
2000; Van Blerkom, 1989a, 1989b, 1993; Van Blerkom and
Motta, 1979; Van Blerkom et al., 1973). The significance of this
mitochondrial remodeling is unclear; however, human embryos
that arrest in vitro often contain mitochondria that have failed
to transform into amore orthodoxmorphology, a step that is pre-
sumably necessary to meet the energy demands of the devel-
oping embryo (Van Blerkom, 1989a).
Finally, mitochondria in oocytes play another critical role in
reproduction: they serve as the source for uniparental inheri-
tance of the mitochondrial genome from one generation to the
next. It is fairly well established that paternal (sperm-derived)
mitochondria are degraded in newly formed embryos within
the first few cleavage divisions, leaving maternally derived mito-
chondria as the sole pool for replication of these organelles in the
embryo and resultant offspring (Cummins, 1998; Giles et al.,
1980; Hutchison et al., 1974; Kaneda et al., 1995; Sutovsky
et al., 2000). Themechanisms underlying this sex-specific selec-
tion against the transmission of paternal mtDNA are not
completely understood. In many species, however, the selection
appears to result from ubiquitination of sperm-derived mito-
chondria, which allows for their subsequent removal from the
embryo (Sutovsky et al., 2004). Equally unclear is why paternal
mtDNA inheritance is actively selected against. One idea is
that it minimizes the transmission of mtDNA mutations that arise
in sperm exposed to ROS during spermatogenesis (Aitken,
1995). Consistent with this idea, sperm mitochondria often har-
bor mtDNA mutations and deletions (Reynier et al., 1998), which
in turn are linked to poor spermmotility and male-factor infertility
(Kao et al., 1995; Ruiz-Pesini et al., 2000; St John et al., 2001).842 Cell Metabolism 17, June 4, 2013 ª2013 Elsevier Inc.Irrespective of the mechanisms that drive uniparental mtDNA
inheritance or the advantages it provides, this process necessi-
tates strict maintenance of mtDNA integrity in the female germ-
line. Otherwise, a cumulative mutational disaster could occur,
as mitochondria from the oocyte are used to seed the new
embryo in each successive generation (Jansen and de Boer,
1998). To ensure asexual maintenance of mitochondrial genome
integrity, a multistep process has been proposed that involves
an initial quantitative restriction on mtDNA genotypes that will
potentially be passed (the so-called ‘‘mitochondrial bottleneck’’),
followed by a period of tremendous amplification. Then, under
pressure to achieve improved fitness in subsequent generations,
a competitive mass selection occurs (Jansen, 2000). The quan-
titative restriction event takes place in the developing embryo
as mtDNA content in the embryo, and mitochondrial numbers
per cell, decline exponentially from peak levels at the fertilized
egg stage to extremely low levels in the implanting blastocyst.
In fact, embryonic primordial germ cells contain ten or fewer
mitochondria per cell, in stark contrast to the hundreds of thou-
sands of mitochondria present in each egg (Jansen and Burton,
2004; Piko´ and Matsumoto, 1976). This latter point exemplifies
the importance of the second step in the process of mtDNA
selection, which entails a period of tremendous amplification
with minimal selection that presumably allows for some degree
of genetic drift (Brown et al., 2001). The third and final stage of
the process—competitive mass selection—is the least estab-
lished in terms of actual mechanism.
One theory is that constant culling of oocyte-containing folli-
cles by atresia serves to identify a given follicle that will release
an egg at ovulation with the highest degree of mtDNA integrity
(Jansen and Burton, 2004; Jansen and de Boer, 1998). Although
this is an attractive proposal, direct evidence for it is currently
lacking. However, the existence of a tightly controlled surveil-
lance system for ensuringmaternal mtDNA integrity is supported
by observations that mtDNA deletions are usually not trans-
mitted to the offspring of clinically symptomatic women. In addi-
tion, the common DmtDNA4977 deletion is greater in unfertilized
human eggs than in early cleavage stage embryos (Brenner
et al., 1998; Perez et al., 2000), and two-thirds of degenerated
or arrested oocytes carry the DmtDNA4977 deletion (Duran
et al., 2011).
Energetics, Aging, and Female Fertility: Connecting
the Dots
Direct causative relationships between impaired mitochondrial
function, suboptimal bioenergetic capacity, and reduced devel-
opmental competency of eggs in aging females have not yet
been unequivocally established. Nevertheless, evidence for
such relationships continues to solidify, as does the link between
longevity pathways and fertility. Studies of hamsters and mice
have reported that maternal aging is associated with significant
decreases in ATP content and mitochondrial numbers in
oocytes. In addition, the demonstration that DR instituted during
adulthood not only benefits multiple parameters of egg quality in
aging female mice (Selesniemi et al., 2011) but also extends the
natural reproductive period (Selesniemi et al., 2008) argues
strongly that the same signaling pathways mediating responses
of somatic cells to DR are also at work in the female germline.
Further supporting this conclusion are recent data showing
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Reduced mitochondrial activity and bioenergetic potential contribute to aging-related impairments in female fertility, even with the use of assisted reproductive
technologies such as IVF. Delivery of mitochondria derived from a patient’s own natural egg precursor cells (OSCs) into that same patient’s eggs during
intracytoplasmic sperm injection raises the threshold level of mitochondria in that egg, providing sufficient energy to support successful fertilization and
embryogenesis.
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et al., 2010; Luo et al., 2012), that DR increases the expression of
sirtuins in the rat ovary (Luo et al., 2012), and that the develop-
ment of embryos arising from oocytes lacking mitochondrial-
associated sirtuin-3 is significantly impaired (Kawamura et al.,
2010).
Although progress has been made in connecting the dots, we
are still far from understanding or manipulating the bioenergetic
and longevity pathways that impact female fertility. Thus, the
experimental and clinical data currently in hand can be viewed
as opening chapters in a saga that may one day offer unprece-
dented opportunities for the clinical management of egg quality,
fertilization, and preimplantation embryogenesis in human assis-
ted reproduction. Looking ahead, we will conclude with two
examples of potential future chapters that integrate many of
the concepts discussed herein.
Autologous Germline Mitochondrial Energy Transfer
and Egg Quality
In the mid to late 1990s, 27 female subjects who had repeatedly
failed to become pregnant following assisted reproduction due
to poor embryo quality and implantation failure participated in
a trial of a new fertility protocol termed ooplasmic transfer (Barritt
et al., 2001; Brenner et al., 2000; Cohen et al., 1997, 1998; Har-
vey et al., 2007). Under the assumption that the recurrent failure
of these women to achieve pregnancies was due, at least in part,
to an age-related impairment in the quality of their eggs, their
next cycle of IVF included transfer of a small amount of cyto-
plasm extracted from young donor oocytes (viz., obtained from
different women) into their oocytes. Thirty attempts of ooplasmictransfer were performed by the first clinic, resulting in 13 live
births (17 babies total, comprised of 11 singletons, 1 set of twins,
and 1 set of quadruplets) and 1 first trimester miscarriage (45, XO
karyotype). The twin pregnancy resulted in birth of a female with
a normal karyotype (46, XX) and a chromosomally abnormal
sibling (45, XO). Of the babies born, the rate of chromosomal
abnormalities (1 of 17, or 5.9%) was within the normal range of
IVF outcomes for women at the ages tested in that region of
the United States (Harvey et al., 2007). The high pregnancy suc-
cess rates achieved in this relatively small cohort of patients,
who had repeatedly failed all prior IVF attempts, raised hopes
that human assisted reproduction would finally have a new tool
in its arsenal to combat infertility associated with poor egg and
embryo quality.
Other clinical sites were quick to join in (Lanzendorf et al.,
1999); however, enthusiasm for widespread adoption of ooplas-
mic transfer as a clinical protocol was short-lived, in part
because of concerns about mitochondrial heteroplasmy (Barritt
et al., 2001; Brenner et al., 2000). Although the procedure
involved transfer of cytoplasm from donor eggs, and not purified
mitochondria, it is widely believed that the benefit to recipient
eggs came from the transfer of active donor mitochondria (Ben-
tov et al., 2011; Van Blerkom et al., 1998). This conclusion has
been substantiated by animal studies (El Shourbagy et al.,
2006; Yi et al., 2007) and, to a degree, by follow-up studies of
the children born through ooplasmic transfer who carry mito-
chondria from both the biological mother and the egg donor
(Brenner et al., 2000; Barritt et al., 2001). At present, the negative
health impact, if any, of heteroplasmy in these children is
unknown, but animal models indicate there may be at leastCell Metabolism 17, June 4, 2013 ª2013 Elsevier Inc. 843
Figure 3. Identification and Utility of Female Germ Cell Mitochondrial Boosters
Culture of human OSCs, which are natural precursor cells for human oocytes, allows high-throughput screening of biological and pharmacological entities for
their ability to increase various aspects of mitochondrial dynamics, including mtDNA content, mitochondrial membrane potential, and ATP-generating capacity.
Positive hits can be further tested using a combination of in vitro and in vivo assays to assess if aging-related impairments in egg quality, embryonic devel-
opmental competence, and fertility can be minimized.
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mitochondrial heteroplasmy can produce an adult-onset pheno-
type consistent with metabolic syndrome (Acton et al., 2007).
Other work has shown that heteroplasmy can also negatively
impact cognitive function (Sharpley et al., 2012).
Additionally, oocyte mitochondria contain genetic material
that is distinct from nuclear genes contributed by the biological
mother and father. Accordingly, the children conceived following
this procedure possess genetic material derived from not two
but three distinct sources: the biological mother, the biological
father, and the egg donor. Aside from an array of potential ethical
and legal issues associated with heterologous ooplasmic trans-
fer, the U.S. Food and Drug Administration (FDA) viewed this
procedure as genetic manipulation of human germ cells for the
purpose of generating embryos. Thus, in 2001 the FDA ruled
that heterologous ooplasmic transfer could no longer be used
for human assisted reproduction unless the procedure was sub-
mitted for review and testing under Investigational New Drug
(IND) guidelines (Zoon, 2001).While use of autologousmitochon-
dria from a woman’s own somatic cells would avoid mito-
chondrial heteroplasmy, somatic mitochondria are prone to
aging-related mtDNA damage resulting in heritable mutations.
Introduction of these mitochondria into oocytes at fertilization
could lead to propagation of mutant mitochondria in newly844 Cell Metabolism 17, June 4, 2013 ª2013 Elsevier Inc.formed embryos and resultant offspring, a risk too great to
consider for clinical protocol development.
However, the discovery that OSCs are present in ovaries not
just of adult mice but also of reproductive age women (Johnson
et al., 2004; White et al., 2012; Zou et al., 2009) has opened pros-
pects for bringing a modified version of ooplasmic transfer into
clinical practice. Termed AUGMENT (for autologous germline
mitochondrial energy transfer; Woods et al., 2013), this proce-
dure would provide an autologous germline-derived source of
cytoplasmic extract or purified mitochondria for the bioenergetic
reinvigoration of eggs whose capacity for fertilization and
embryogenesis has been compromised by aging (Figure 2).
The use of OSCs as a source of mitochondria for enhancing
egg and embryo quality is attractive for reasons other than
simply being a patient-matched source of these important en-
ergy-boosting organelles. First, since OSCs function as natural
precursor cells for the generation of oocytes (White et al.,
2012; Zou et al., 2009), if mitochondria in the female germline
are indeedmanaged quite differently from those in somatic cells,
the use of OSCs as a source of mitochondria for rejuvenation of
eggs would be compatible with the natural processes of surveil-
lance and selection that govern maternal mitochondrial transfer
from one generation to the next. Second, OSC mitochondria,
being derived from slowly dividing stem/progenitor cells, are
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Figure 4. Negative Impact of Maternal Aging on Ovulated Egg Quality and Female Fertility
Schematic depiction of howmaternal aging-associated deficits in bioenergetic potential in oocytes compromise their ability to form fertilization-competent eggs.
Insufficient energy in the eggs of older females leads to impaired meiotic spindle formation and maintenance, unequal segregation of genetic material at the
completion of meiosis during fertilization, and aneuploid conceptions, which result in preimplantation embryonic growth arrest, implantation failure, miscarriage,
and birth defects.
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than mitochondria in patient-matched somatic cells. Preliminary
observations from studies of human OSCs support this conten-
tion (Woods and Tilly, 2013). Perhaps equally important are
observations that the bioenergetic potential of mitochondria in
human OSCs, as measured by ATP generation over time, far
exceeds that of equivalent numbers of mitochondria isolated
from several other human cell lineages, including embryonic
and adult somatic stem cells (Woods and Tilly, 2013). Finally,
the cell lineage-specific transfer of key nuclear-encoded pro-
teins into mitochondria would be better preserved through the
use of OSCs versus nongermline cells. Given all of these consid-
erations, along with the preclinical and clinical proof-of-concept
data available from prior studies discussed above, the use of
AUGMENT for safely improving human assisted reproduction
without the ethical, legal, and biological issues surrounding het-
erologous ooplasmic transfer is an exciting prospect to consider.
Mitochondrial Activators to Boost Egg Quality
Another potential approach to overcoming energy deficits in
eggs is to identify new biological and chemical entities that
enhance mitochondrial numbers or the efficacy of mitochondrial
ATP generation in oocytes. The development of such com-
pounds that safely reproduce the striking benefits of DR on
egg quality in aging females (Selesniemi et al., 2011) could repre-
sent a significant leap forward in human assisted reproduction.The main hurdle faced is the extreme rarity of oocytes for con-
ducting large-scale mitochondrial screening assays, coupled
with the cost and complexities of performing aging studies
with mice. However, the availability of mouse and human
OSCs, which can be maintained and expanded ex vivo to
generate essentially unlimited numbers of cells for screening
(White et al., 2012), may provide a solution (Figure 3). Because
these cells function as natural oocyte progenitors, it is reason-
able to predict that compounds identified as mitochondrial
boosters in OSCs would exhibit similar properties in oocytes.
In addition, use of OSCs as a screening platform offers an oppor-
tunity to map molecular events through which a given com-
pound, or family of compounds, boosts mitochondrial numbers
or activity in female germ cells. Such studies would further
benefit by generating OSC lines that carry desired manipulations
of key components of the longevity regulatory pathways dis-
cussed earlier (Figure 1). Establishment of these types of female
germ cell lines could facilitate identification of control points that
coordinate bioenergetic potential in oocytes. In turn, this may
lead to a more directed approach for identifying potential lead
compounds that could be tested in aging female mice for their
ability to improve egg quality.
There is ample reason to believe that IVF outcomes for
patients with energetically compromised eggs or embryos would
benefit from mitochondrial activators (Bentov et al., 2010; Van
Blerkom, 2011), similar to the energetic boost provided to eggsCell Metabolism 17, June 4, 2013 ª2013 Elsevier Inc. 845
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Perspectiveby direct mitochondrial transfer. However, mitochondrial activa-
tors may also prove valuable as in vivo agents to ensure that
oocytes ultimately released from the ovaries at ovulation or
retrieved from IVF patients after ovarian stimulation are fully pre-
pared, from a bioenergetic perspective, to undergo the final
maturational steps needed for full developmental competency.
One example of their potential utility would be to combat the
increase in oocyte aneuploidy associated with maternal repro-
ductive aging, a process that, at least in mice, has been tied to
mitochondrial dysfunction and energy deficits in the ovulated
eggs (Selesniemi et al., 2011).
Mechanistically, the formation andmaintenance of the meiotic
spindle is an energy-driven process that is highly susceptible to
failure in oocytes of aged females (Figure 4). The resultant chro-
mosomal misalignment or unequal chromosomal segregation
produces an egg with too few or too many chromosomes, lead-
ing to genetic errors that can be passed to resultant embryos af-
ter fertilization (Gaulden, 1992). Clinically, maternal aging-related
increases in egg and embryo aneuploidy are tied directly to par-
allel increases in trisomic conceptions, implantation failures, and
miscarriages (Benadiva et al., 1996; Hassold and Chiu, 1985;
Munne´ and Cohen, 1998; Munne´ et al., 1995). Identification of
orally active compounds that boost the energetic capacity of oo-
cytes prior to ovulation or retrieval for IVFmay therefore provide a
novel strategy to maximize the chances of obtaining eggs from
females at advanced reproductive ages that are free fromgenetic
errors and other problems that contribute to postfertilization em-
bryonic failure. In turn, such strategies might also mitigate the
maternal aging-related increase in risk for miscarriage and birth
defects, including Down syndrome.ACKNOWLEDGMENTS
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